• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

曲伐沙星，一种对肺炎链球菌具有强效活性的新型氟喹诺酮类药物。

Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.

作者信息

Thomson K S, Chartrand S A, Sanders C C, Block S L

机构信息

Department of Medical Microbiology and Immunology, Creighton University, School of Medicine, Omaha, Nebraska 68178, USA.

出版信息

Antimicrob Agents Chemother. 1997 Feb;41(2):478-80. doi: 10.1128/AAC.41.2.478.

DOI:10.1128/AAC.41.2.478
PMID:9021213
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC163735/
Abstract

An in vitro study of the activity of 15 antibacterial agents against 202 recent pediatric isolates of Streptococcus pneumoniae from urban and rural Nebraska and rural Kentucky identified trovafloxacin, ofloxacin, clindamycin, and vancomycin as the most active agents and equally active against both penicillin-susceptible and--resistant strains. In contrast, six beta-lactams, three macrolides, and trimethoprim-sulfamethoxazole were less active overall, especially against penicillin-intermediate and--resistant strains. Trovafloxacin inhibited all strains at a concentration of < or = 0.25 micrograms/ml and was 8- to 16-fold more potent than ofloxacin or ciprofloxacin.

摘要

一项针对来自内布拉斯加州城乡以及肯塔基州农村地区的202株近期儿科肺炎链球菌分离株，对15种抗菌剂活性的体外研究表明，曲伐沙星、氧氟沙星、克林霉素和万古霉素是活性最强的药物，对青霉素敏感和耐药菌株的活性相同。相比之下，六种β-内酰胺类药物、三种大环内酯类药物以及甲氧苄啶-磺胺甲恶唑总体活性较低，尤其是对青霉素中介和耐药菌株。曲伐沙星在浓度≤0.25微克/毫升时可抑制所有菌株，其效力比氧氟沙星或环丙沙星强8至16倍。

相似文献

1
Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.曲伐沙星，一种对肺炎链球菌具有强效活性的新型氟喹诺酮类药物。
Antimicrob Agents Chemother. 1997 Feb;41(2):478-80. doi: 10.1128/AAC.41.2.478.
2
Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.曲伐沙星对1997 - 1998年呼吸道感染季节分离出的3049株肺炎链球菌的抗菌活性比较
Diagn Microbiol Infect Dis. 1998 Oct;32(2):119-26. doi: 10.1016/s0732-8893(98)00072-8.
3
Activity of trovafloxacin against blood isolates of Streptococcus pneumoniae in Sweden.曲伐沙星对瑞典肺炎链球菌血液分离株的活性。
Eur J Clin Microbiol Infect Dis. 1996 Aug;15(8):671-5. doi: 10.1007/BF01691157.
4
In-vitro activity of the fluoroquinolone trovafloxacin against penicillin-susceptible and -resistant Streptococcus pneumoniae.氟喹诺酮类药物曲伐沙星对青霉素敏感和耐药肺炎链球菌的体外活性
J Antimicrob Chemother. 1995 Nov;36(5):873-4. doi: 10.1093/jac/36.5.873.
5
In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia.捷克共和国和斯洛伐克肺炎球菌对曲伐沙星、青霉素G及其他抗菌药物的体外敏感性
Eur J Clin Microbiol Infect Dis. 1996 Aug;15(8):686-8. doi: 10.1007/BF01691161.
6
In-vitro and in-vivo activity of trovafloxacin against Streptococcus pneumoniae.曲伐沙星对肺炎链球菌的体外及体内活性
J Antimicrob Chemother. 1997 Jun;39 Suppl B:51-5. doi: 10.1093/jac/39.suppl_2.51.
7
In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance.
J Antimicrob Chemother. 1999 Jun;43 Suppl C:15-9. doi: 10.1093/jac/43.suppl_3.15.
8
Comparative activity of trovafloxacin and Bay 12-8039 against 452 clinical isolates of Streptococcus pneumoniae.曲伐沙星与Bay 12 - 8039对452株肺炎链球菌临床分离株的活性比较
J Antimicrob Chemother. 1998 Oct;42(4):523-5. doi: 10.1093/jac/42.4.523.
9
Determining the frequency of resistance of Streptococcus pneumoniae to ciprofloxacin, levofloxacin, trovafloxacin, grepafloxacin, and gemifloxacin.测定肺炎链球菌对环丙沙星、左氧氟沙星、曲伐沙星、格帕沙星和吉米沙星的耐药频率。
Eur J Clin Microbiol Infect Dis. 2001 Dec;20(12):883-5. doi: 10.1007/s10096-001-0636-6.
10
Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.新型氟喹诺酮曲伐沙星（CP-99,219）对体外筛选的肺炎链球菌DNA旋转酶和拓扑异构酶IV突变体的活性。
Antimicrob Agents Chemother. 1996 Dec;40(12):2691-7. doi: 10.1128/AAC.40.12.2691.

引用本文的文献

1
Microbial Resistance to Antibiotics and Effective Antibiotherapy.微生物对抗生素的耐药性与有效的抗生素治疗
Biomedicines. 2022 May 12;10(5):1121. doi: 10.3390/biomedicines10051121.
2
Pneumococcal Epidural Abscess in an Asplenic Patient Presenting After Mild Hip Trauma.一位无脾患者在轻度髋部创伤后出现肺炎球菌性硬膜外脓肿。
Cureus. 2020 Mar 31;12(3):e7494. doi: 10.7759/cureus.7494.
3
Clinical evaluation of the tolerability and efficacy of trovafloxacin compared with sparfloxacin in the treatment of lower respiratory tract infections.比较托氟沙星与司帕沙星治疗下呼吸道感染的耐受性和疗效的临床评估。
Clin Drug Investig. 2000;20(2):95-100. doi: 10.2165/00044011-200020020-00004.
4
The new fluoroquinolones: A critical review.新型氟喹诺酮类药物：批判性综述。
Can J Infect Dis. 1999 May;10(3):207-38. doi: 10.1155/1999/378394.
5
Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia.乙醇对肺炎球菌肺炎大鼠模型中氟喹诺酮疗效的影响。
Antimicrob Agents Chemother. 2006 Jan;50(1):210-9. doi: 10.1128/AAC.50.1.210-219.2006.
6
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States.美国2000 - 2001年和2001 - 2002年TRUST研究中儿童肺炎链球菌、流感嗜血杆菌和卡他莫拉菌临床分离株对左氧氟沙星的敏感性
Antimicrob Agents Chemother. 2003 Jun;47(6):1790-7. doi: 10.1128/AAC.47.6.1790-1797.2003.
7
Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin.单剂量静脉注射阿拉曲沙星后，氟萘啶酮（曲伐沙星，CP 99,219）在婴幼儿和儿童中的药代动力学。
Antimicrob Agents Chemother. 2000 May;44(5):1195-9. doi: 10.1128/AAC.44.5.1195-1199.2000.
8
Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.曲伐沙星单独及与β-内酰胺类药物、利福平或万古霉素联合使用时，针对在脑脊液中可达到的临床浓度下对超广谱头孢菌素具有不同敏感性的肺炎链球菌分离株的杀菌活性。
Antimicrob Agents Chemother. 1999 Oct;43(10):2372-5. doi: 10.1128/AAC.43.10.2372.
9
Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.在体外药代动力学模型中，曲伐沙星、氧氟沙星和环丙沙星对肺炎链球菌的药效学研究
Antimicrob Agents Chemother. 1999 May;43(5):1118-23. doi: 10.1128/AAC.43.5.1118.
10
In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone.新型去-F(6)-喹诺酮T-3811ME的体外和体内抗菌活性
Antimicrob Agents Chemother. 1999 May;43(5):1077-84. doi: 10.1128/AAC.43.5.1077.

本文引用的文献

1
New prospects for antibacterial agents against multidrug-resistant pneumococci.抗多重耐药肺炎球菌抗菌药物的新前景
Microb Drug Resist. 1995 Spring;1(1):43-8. doi: 10.1089/mdr.1995.1.43.
2
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.DU-6859a、环丙沙星、左氧氟沙星、司帕沙星、头孢噻肟、亚胺培南及万古霉素对9株青霉素敏感及耐药肺炎球菌活性的最低抑菌浓度（MIC）及时间杀菌研究
Antimicrob Agents Chemother. 1996 Feb;40(2):362-6. doi: 10.1128/AAC.40.2.362.
3
Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics.
J Antimicrob Chemother. 1995 Dec;36(6):1043-8. doi: 10.1093/jac/36.6.1043.
4
Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.未受损害的耐青霉素肺炎球菌肺炎CBA/J小鼠模型及该模型中抗生素的比较疗效。
Antimicrob Agents Chemother. 1996 Jun;40(6):1520-5. doi: 10.1128/AAC.40.6.1520.
5
Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.1994年至1995年冬季美国门诊患者中分离出的肺炎链球菌的耐药性：一项30中心全国监测研究的结果
Antimicrob Agents Chemother. 1996 May;40(5):1208-13. doi: 10.1128/AAC.40.5.1208.
6
Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.采用时间杀菌法比较CP 99,219（曲伐沙星）与环丙沙星、司帕沙星、克林沙星、洛美沙星及头孢呋辛对10株青霉素敏感和青霉素耐药肺炎球菌的活性。
J Antimicrob Chemother. 1996 Jan;37(1):77-84. doi: 10.1093/jac/37.1.77.
7
In-vitro activity of the fluoroquinolone trovafloxacin against penicillin-susceptible and -resistant Streptococcus pneumoniae.氟喹诺酮类药物曲伐沙星对青霉素敏感和耐药肺炎链球菌的体外活性
J Antimicrob Chemother. 1995 Nov;36(5):873-4. doi: 10.1093/jac/36.5.873.
8
Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease.镰状细胞病患儿中耐抗生素肺炎链球菌的定植情况。
J Pediatr. 1996 Apr;128(4):531-5. doi: 10.1016/s0022-3476(96)70365-7.
9
Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center.一家日托中心出现对青霉素耐药的肺炎链球菌定植情况。
Pediatr Infect Dis J. 1995 Oct;14(10):879-84. doi: 10.1097/00006454-199510000-00012.
10
A comparative study of the in-vitro activity of cefepime and other antimicrobial agents against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.头孢吡肟与其他抗菌药物对青霉素敏感和耐药肺炎链球菌体外活性的比较研究。
J Antimicrob Chemother. 1993 Nov;32 Suppl B:13-9. doi: 10.1093/jac/32.suppl_b.13.